LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $45,855,926
Key CONT_AWD_75N91020F00021_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 80 days before this system saw it. One version on record.
Cite this row
4d7b0640612849f6c792b65d53f520ed38622328e6f2ae405df4ef024686088cThe source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $45,855,926 | first version | September 25, 2020 | June 17, 2026 | 2026-09-05T00:54:36Z | historical sweep | 4d7b06406128 |
Archived copy
https://web.archive.org/web/20261011024435/https://www.usaspending.gov/award/CONT_AWD_75N91020F00021_7529_75N91019D00024_7529 captured by this system, October 11, 2026
What the amount is made of
12 recorded actions, so the amount is the award's current total across all of them. 7 of them obligated money. Measured 2026-10-12, when USAspending reported a total obligation of $45,855,926.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| June 17, 2026 | P00011 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | +$3,749,767 | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM |
| April 9, 2026 | P00010 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | +$11,249,899 | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM |
| September 29, 2025 | P00009 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | +$3,192,111 | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM |
| July 21, 2025 | P00008 | OTHER ADMINISTRATIVE ACTION | no money | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM |
| May 5, 2025 | P00007 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | +$5,624,623 | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM |
| April 27, 2023 | P00006 | OTHER ADMINISTRATIVE ACTION | +$17,137,213 | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM |
| January 19, 2023 | P00005 | OTHER ADMINISTRATIVE ACTION | +$904,846 | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM |
| June 30, 2022 | P00004 | OTHER ADMINISTRATIVE ACTION | no money | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM |
| June 14, 2022 | P00003 | OTHER ADMINISTRATIVE ACTION | no money | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM |
| March 8, 2022 | P00002 | OTHER ADMINISTRATIVE ACTION | no money | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM |
| November 30, 2021 | P00001 | OTHER ADMINISTRATIVE ACTION | no money | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM |
| September 25, 2020 | base | not on file | +$3,997,467 | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM |
Last refreshed November 4, 2026 at 2:31 PM UTC.